395 related articles for article (PubMed ID: 18516322)
1. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
6. Biological analysis of gastrointestinal stromal tumors.
Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
[TBL] [Abstract][Full Text] [Related]
7. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
8. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E
Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors].
Ramos Soler D; Navarro Fos S; Villamón Fort R; Gil Salom M; Llombart Bosch A
Arch Esp Urol; 2003 Apr; 56(3):277-85. PubMed ID: 12768988
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
Ohmura Y; Aoe M; Andou A; Shimizu N
Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
[TBL] [Abstract][Full Text] [Related]
13. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
[TBL] [Abstract][Full Text] [Related]
14. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
18. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity (Ki-67), WT p53, Bcl-2 expression and their relationship to the tumor grade, in invasive ductal breast carcinomas.
Kalogeraki A; Garbagnati F; Santinami M; Zoras O
In Vivo; 2002; 16(2):141-4. PubMed ID: 12073773
[TBL] [Abstract][Full Text] [Related]
20. Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer.
Nagy B; Tiszlavicz L; Eller J; Molnar J; Thurzo L
In Vivo; 2003; 17(1):93-6. PubMed ID: 12655798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]